{
    "xml": "<topic id=\"PHP7778\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/pimecrolimus\" basename=\"pimecrolimus\" title=\"PIMECROLIMUS\">\n<title>PIMECROLIMUS</title>\n<body>\n<data name=\"vtmid\">385581009</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_729481638\" title=\"Calcineurin inhibitors and related drugs\">Calcineurin inhibitors and related drugs</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n</body>\n<topic id=\"PHP49480\" outputclass=\"indicationsAndDose\" rev=\"1.13\" parent=\"/drugs/pimecrolimus\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Short-term treatment of mild to moderate atopic eczema (including flares) when topical corticosteroids cannot be used (initiated by a specialist)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the skin</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Apply twice daily until symptoms resolve (stop treatment if eczema worsens or no response after 6 weeks).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Short-term treatment of facial, flexural, or genital psoriasis in patients unresponsive to, or intolerant of other topical therapy (initiated by a specialist)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the skin</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Apply twice daily until symptoms resolve (maximum duration of treatment 4 weeks).</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49404\" outputclass=\"unlicensedUse\" rev=\"1.8\" parent=\"/drugs/pimecrolimus\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p>Pimecrolimus is not licensed for short-term treatment of facial, flexural, or genital psoriasis in patients unresponsive to, or intolerant of other topical therapy.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49543\" outputclass=\"contraindications\" rev=\"1.10\" parent=\"/drugs/pimecrolimus\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Application to malignant or potentially malignant skin lesions</ph>; <ph outputclass=\"contraindication\">application under occlusion</ph>; <ph outputclass=\"contraindication\">congenital epidermal barrier defects</ph>; <ph outputclass=\"contraindication\">contact with eyes</ph>; <ph outputclass=\"contraindication\">contact with mucous membranes</ph>; <ph outputclass=\"contraindication\">generalised erythroderma</ph>; <ph outputclass=\"contraindication\">immunodeficiency</ph>; <ph outputclass=\"contraindication\">infection at treatment site</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49574\" outputclass=\"cautions\" rev=\"1.12\" parent=\"/drugs/pimecrolimus\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Alcohol consumption (risk of facial flushing and skin irritation)</ph>; <ph outputclass=\"caution\">avoid other topical treatments except emollients at treatment site</ph>; <ph outputclass=\"caution\">UV light (avoid excessive exposure to sunlight and sunlamps)</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49467\" outputclass=\"interactions\" rev=\"1.18\" parent=\"/drugs/pimecrolimus\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Concomitant use with drugs that cause immunosuppression is contraindicated (may be prescribed in exceptional circumstances by specialists).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49421\" outputclass=\"sideEffects\" rev=\"1.10\" parent=\"/drugs/pimecrolimus\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Burning sensation</ph>; <ph outputclass=\"sideEffect\">erythema</ph>; <ph outputclass=\"sideEffect\">folliculitis</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">skin infections</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Herpes simplex</ph>; <ph outputclass=\"sideEffect\">herpes zoster</ph>; <ph outputclass=\"sideEffect\">impetigo</ph>; <ph outputclass=\"sideEffect\">molluscum contagiosum</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Dryness</ph>; <ph outputclass=\"sideEffect\">local reactions including pain</ph>; <ph outputclass=\"sideEffect\">oedema</ph>; <ph outputclass=\"sideEffect\">papilloma</ph>; <ph outputclass=\"sideEffect\">paraesthesia</ph>; <ph outputclass=\"sideEffect\">peeling</ph>; <ph outputclass=\"sideEffect\">skin discoloration</ph>; <ph outputclass=\"sideEffect\">worsening of eczema</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Skin malignancy</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49461\" outputclass=\"pregnancy\" parent=\"/drugs/pimecrolimus\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid; toxicity in <i>animal</i> studies following systemic administration.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49584\" outputclass=\"breastFeeding\" parent=\"/drugs/pimecrolimus\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises caution; ensure infant does not come in contact with treated areas.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49379\" outputclass=\"nationalFunding\" rev=\"1.20\" parent=\"/drugs/pimecrolimus\">\n<title>National funding/access decisions</title>\n<body>\r\n<section>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisals\">\r\n<p outputclass=\"title\">NICE technology appraisals (TAs)</p>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisal\">\r\n<p outputclass=\"fundingIdentifier\">NICE TA82</p>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Tacrolimus and pimecrolimus for atopic eczema (August 2004)</p>\r\n<p>Topical pimecrolimus is an option for atopic eczema not controlled by maximal topical corticosteroid treatment or if there is a risk of important corticosteroid side-effects (particularly skin atrophy).</p>\r\n<p>Topical pimecrolimus is recommended for moderate atopic eczema on the face and neck of children aged 2&#8211;16 years . Pimecrolimus should be used within its licensed indications.</p>\n</sectiondiv>\n<xref format=\"html\" href=\"http://www.nice.org.uk/TA82\">www.nice.org.uk/TA82</xref>\n</sectiondiv>\n</sectiondiv>\r\n </section>\r\n\r\n</body>\n</topic>\n<topic id=\"PHP7778-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/pimecrolimus\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76099\" title=\"Cream\" namespace=\"/drugs/pimecrolimus/cream\">Cream</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78311\" namespace=\"/treatment-summaries/eczema\" title=\"Eczema\" count=\"1\" rel=\"backlink\">Eczema</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78319\" namespace=\"/treatment-summaries/psoriasis\" title=\"Psoriasis\" count=\"1\" rel=\"backlink\">Psoriasis</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78375\" namespace=\"/treatment-summaries/eczema-and-psoriasis-drugs-affecting-the-immune-response\" title=\"Eczema and psoriasis, drugs affecting the immune response\" count=\"3\" rel=\"backlink\">Eczema and psoriasis, drugs affecting the immune response</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76099\" namespace=\"/drugs/pimecrolimus/cream\" title=\"Cream\" count=\"1\" rel=\"link\">Cream</xref>\n</links>\n</topic>",
    "id": "PHP7778",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/pimecrolimus",
    "basename": "pimecrolimus",
    "title": "PIMECROLIMUS",
    "vtmid": "385581009",
    "drugClassification": [
        "Calcineurin inhibitors and related drugs"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Short-term treatment of mild to moderate atopic eczema (including flares) when topical corticosteroids cannot be used (initiated by a specialist)",
                        "html": "Short-term treatment of mild to moderate atopic eczema (including flares) when topical corticosteroids cannot be used (initiated by a specialist)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the skin"
                    ],
                    "textContent": "To the skin",
                    "html": "To the skin"
                },
                "adult": [
                    {
                        "textContent": "Apply twice daily until symptoms resolve (stop treatment if eczema worsens or no response after 6 weeks).",
                        "html": "<p>Apply twice daily until symptoms resolve (stop treatment if eczema worsens or no response after 6 weeks).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Short-term treatment of facial, flexural, or genital psoriasis in patients unresponsive to, or intolerant of other topical therapy (initiated by a specialist)",
                        "html": "Short-term treatment of facial, flexural, or genital psoriasis in patients unresponsive to, or intolerant of other topical therapy (initiated by a specialist)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the skin"
                    ],
                    "textContent": "To the skin",
                    "html": "To the skin"
                },
                "adult": [
                    {
                        "textContent": "Apply twice daily until symptoms resolve (maximum duration of treatment 4 weeks).",
                        "html": "<p>Apply twice daily until symptoms resolve (maximum duration of treatment 4 weeks).</p>"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "textContent": "Pimecrolimus is not licensed for short-term treatment of facial, flexural, or genital psoriasis in patients unresponsive to, or intolerant of other topical therapy.",
                "html": "<p>Pimecrolimus is not licensed for short-term treatment of facial, flexural, or genital psoriasis in patients unresponsive to, or intolerant of other topical therapy.</p>"
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Application to malignant or potentially malignant skin lesions",
                "html": "Application to malignant or potentially malignant skin lesions"
            },
            {
                "type": "contraindications",
                "textContent": "application under occlusion",
                "html": "application under occlusion"
            },
            {
                "type": "contraindications",
                "textContent": "congenital epidermal barrier defects",
                "html": "congenital epidermal barrier defects"
            },
            {
                "type": "contraindications",
                "textContent": "contact with eyes",
                "html": "contact with eyes"
            },
            {
                "type": "contraindications",
                "textContent": "contact with mucous membranes",
                "html": "contact with mucous membranes"
            },
            {
                "type": "contraindications",
                "textContent": "generalised erythroderma",
                "html": "generalised erythroderma"
            },
            {
                "type": "contraindications",
                "textContent": "immunodeficiency",
                "html": "immunodeficiency"
            },
            {
                "type": "contraindications",
                "textContent": "infection at treatment site",
                "html": "infection at treatment site"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Alcohol consumption (risk of facial flushing and skin irritation)",
                "html": "Alcohol consumption (risk of facial flushing and skin irritation)"
            },
            {
                "type": "cautions",
                "textContent": "avoid other topical treatments except emollients at treatment site",
                "html": "avoid other topical treatments except emollients at treatment site"
            },
            {
                "type": "cautions",
                "textContent": "UV light (avoid excessive exposure to sunlight and sunlamps)",
                "html": "UV light (avoid excessive exposure to sunlight and sunlamps)"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Concomitant use with drugs that cause immunosuppression is contraindicated (may be prescribed in exceptional circumstances by specialists).",
                "html": "<p>Concomitant use with drugs that cause immunosuppression is contraindicated (may be prescribed in exceptional circumstances by specialists).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Burning sensation",
                        "html": "Burning sensation",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "erythema",
                        "html": "erythema",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "folliculitis",
                        "html": "folliculitis",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "skin infections",
                        "html": "skin infections",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Herpes simplex",
                        "html": "Herpes simplex",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "herpes zoster",
                        "html": "herpes zoster",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "impetigo",
                        "html": "impetigo",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "molluscum contagiosum",
                        "html": "molluscum contagiosum",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Dryness",
                        "html": "Dryness",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "local reactions including pain",
                        "html": "local reactions including pain",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "oedema",
                        "html": "oedema",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "papilloma",
                        "html": "papilloma",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "paraesthesia",
                        "html": "paraesthesia",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "peeling",
                        "html": "peeling",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "skin discoloration",
                        "html": "skin discoloration",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "worsening of eczema",
                        "html": "worsening of eczema",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Skin malignancy",
                        "html": "Skin malignancy",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid; toxicity in animal studies following systemic administration.",
                "html": "<p>Manufacturer advises avoid; toxicity in <i>animal</i> studies following systemic administration.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises caution; ensure infant does not come in contact with treated areas.",
                "html": "<p>Manufacturer advises caution; ensure infant does not come in contact with treated areas.</p>"
            }
        ]
    },
    "nationalFunding": {
        "niceTechnologyAppraisals": [
            {
                "type": "niceTechnologyAppraisals",
                "references": [
                    {
                        "id": "http://www.nice.org.uk/TA82",
                        "label": "www.nice.org.uk/TA82"
                    }
                ],
                "fundingIdentifier": "NICE TA82",
                "textContent": "Tacrolimus and pimecrolimus for atopic eczema (August 2004) Topical pimecrolimus is an option for atopic eczema not controlled by maximal topical corticosteroid treatment or if there is a risk of important corticosteroid side-effects (particularly skin atrophy). Topical pimecrolimus is recommended for moderate atopic eczema on the face and neck of children aged 2&#8211;16 years . Pimecrolimus should be used within its licensed indications.\n\nwww.nice.org.uk/TA82",
                "html": "<p outputclass=\"title\">Tacrolimus and pimecrolimus for atopic eczema (August 2004)</p> <p>Topical pimecrolimus is an option for atopic eczema not controlled by maximal topical corticosteroid treatment or if there is a risk of important corticosteroid side-effects (particularly skin atrophy).</p> <p>Topical pimecrolimus is recommended for moderate atopic eczema on the face and neck of children aged 2&#8211;16 years . Pimecrolimus should be used within its licensed indications.</p><xref format=\"html\" href=\"http://www.nice.org.uk/TA82\">www.nice.org.uk/TA82</xref>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76099",
                "label": "Cream",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78311",
                "label": "Eczema",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78319",
                "label": "Psoriasis",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78375",
                "label": "Eczema and psoriasis, drugs affecting the immune response",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76099",
                "label": "Cream",
                "type": "medicinalForm"
            }
        ]
    }
}